InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-15.4%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Gilbert Halley E, Directeur Juridique. Officer active across 3 companies, notably Neogenomics INC. In total, 14 disclosures have been published. History available since 17 August 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
2,265 sharesCommon StockSEC:0001601360-26-000002:0
5,778 shares0Common StockSEC:0001628280-26-042040:0
10,139 shares0Common StockSEC:0001787306-24-000100:0
1,550 shares0Common StockSEC:0001649094-24-000013:0
18,200 shares@ US$5.35100.0% of flowCommon StockSEC:0001415889-24-015590:0
2,500 shares0Common StockSEC:0001209191-23-037501:0
4,375 shares0Common StockSEC:0001787306-23-000056:0
3,125 shares0Common StockSEC:0001209191-22-034050:0
4,312 shares0Common StockSEC:0001567619-22-012319:0
42,036 shares0Common StockSEC:0001077183-22-000044:0
45,858 shares0Common StockSEC:0001077183-21-000272
45,858 shares0Common StockSEC:0001077183-21-000272:0
59,228 shares0Common StockSEC:0001077183-21-000214:0
59,228 shares0Common StockSEC:0001077183-21-000214
14 of 14 declarations
About Gilbert Halley E
Halley E. Gilbert is the Chief Legal Officer and Director at NEOGENOMICS INC, Vaxcyte, Inc., and Arcutis Biotherapeutics, Inc. In these roles, he is responsible for managing legal affairs and regulatory compliance. Halley brings valuable expertise in the legal field, contributing to the overall strategy of the companies.
